SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-133705
Filing Date
2020-05-05
Accepted
2020-05-05 16:08:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6460
2 GRAPHIC g846749g34u39.jpg GRAPHIC 3815
  Complete submission text file 0001193125-20-133705.txt   12800
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)